Donald Lee Drakeman
Algemeen Directeur bij GenPharm International LLC
Profiel
Donald Lee Drakeman is the founder of Genmab A, founded in 1999, and Medarex, Inc., founded in 1987.
At Medarex, Inc., he held the title of President & Chief Executive Officer from 1987 to 2006.
Currently, he holds multiple positions including President & Chief Executive Officer at GenPharm International LLC, Chairman at New Jersey Commission on Science & Technology, Director at Gem Pharmaceuticals LLC, and Venture Partner at Advent Venture Partners LLP since 2007.
He has also held former positions such as Chairman at Celldex Therapeutics, Inc. (Old), Independent Director at Zymeworks BC, Inc., Director-Executive Board at 4-Antibody AG, Director at IDM Pharma, Inc., and Faculty Member at Princeton University.
Dr. Drakeman has a graduate degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from Dartmouth College, and a doctorate degree from Princeton University.
Actieve functies van Donald Lee Drakeman
Bedrijven | Functie | Begin |
---|---|---|
GenPharm International LLC
GenPharm International LLC BiotechnologyHealth Technology GenPharm International, Inc. manufactures biopharmaceutical products. The company works towards the application of transgenic animal technology to the development of human antibody products, which are used for therapeutic uses. It was founded in 1988 and is located in San Jose, CA. | Algemeen Directeur | - |
New Jersey Commission on Science & Technology | Voorzitter | - |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01-01-2007 |
Gem Pharmaceuticals LLC
Gem Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Gem Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company that develops anthracycline derivatives used to eliminate cardiotoxicity side effect in chemotherapeutics. The company is headquartered in Birmingham, AL. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Donald Lee Drakeman
Bedrijven | Functie | Einde |
---|---|---|
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 01-06-2007 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Algemeen Directeur | 05-11-2006 |
Princeton University | Corporate Officer/Principal | - |
GENMAB A/S | Oprichter | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | - |
Opleiding van Donald Lee Drakeman
The Trustees of Columbia University in The City of New York | Graduate Degree |
Dartmouth College | Undergraduate Degree |
Princeton University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GENMAB A/S | Health Technology |
Bedrijven in privébezit | 9 |
---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Celldex Therapeutics, Inc. (Old)
Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Celldex Therapeutics, Inc. discovers, develops and commercialized novel immunotherapeutics. It offers treatment for cancer, infectious diseased and immune system disorders. The company was founded in May, 2003 and is headquartered in Philipsburg, NJ. | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
GenPharm International LLC
GenPharm International LLC BiotechnologyHealth Technology GenPharm International, Inc. manufactures biopharmaceutical products. The company works towards the application of transgenic animal technology to the development of human antibody products, which are used for therapeutic uses. It was founded in 1988 and is located in San Jose, CA. | Health Technology |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Health Technology |
New Jersey Commission on Science & Technology | Government |
Gem Pharmaceuticals LLC
Gem Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Gem Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company that develops anthracycline derivatives used to eliminate cardiotoxicity side effect in chemotherapeutics. The company is headquartered in Birmingham, AL. | Health Technology |